Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9404 |
High Similarity |
NPD7075 |
Discontinued |
0.9333 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.9247 |
High Similarity |
NPD6799 |
Approved |
0.9139 |
High Similarity |
NPD6801 |
Discontinued |
0.9097 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9097 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9054 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9034 |
High Similarity |
NPD1549 |
Phase 2 |
0.9007 |
High Similarity |
NPD6599 |
Discontinued |
0.8896 |
High Similarity |
NPD3817 |
Phase 2 |
0.8889 |
High Similarity |
NPD1934 |
Approved |
0.8831 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8824 |
High Similarity |
NPD7411 |
Suspended |
0.8808 |
High Similarity |
NPD5403 |
Approved |
0.8782 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8758 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8758 |
High Similarity |
NPD4380 |
Phase 2 |
0.8688 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8688 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8688 |
High Similarity |
NPD6166 |
Phase 2 |
0.8675 |
High Similarity |
NPD5401 |
Approved |
0.8654 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8639 |
High Similarity |
NPD2796 |
Approved |
0.8599 |
High Similarity |
NPD3882 |
Suspended |
0.859 |
High Similarity |
NPD7819 |
Suspended |
0.8571 |
High Similarity |
NPD1510 |
Phase 2 |
0.8552 |
High Similarity |
NPD1240 |
Approved |
0.8545 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8537 |
High Similarity |
NPD6797 |
Phase 2 |
0.8535 |
High Similarity |
NPD5402 |
Approved |
0.8497 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8485 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8481 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8471 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8435 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8434 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8431 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8414 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8366 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8364 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8344 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8303 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8289 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8278 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8267 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8253 |
Intermediate Similarity |
NPD7472 |
Approved |
0.825 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8242 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.821 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8204 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8199 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8182 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.817 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8163 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.816 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8155 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.811 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8084 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8037 |
Intermediate Similarity |
NPD919 |
Approved |
0.8026 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7976 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7975 |
Intermediate Similarity |
NPD920 |
Approved |
0.7966 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7962 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7962 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7961 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7961 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7961 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7945 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7935 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7905 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7888 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7871 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7871 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7848 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7841 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7834 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7823 |
Intermediate Similarity |
NPD2797 |
Approved |
0.78 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7798 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7785 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7771 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7763 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7763 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7763 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7738 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7736 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7707 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7706 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7679 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7677 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7677 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7671 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7671 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7658 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7654 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7643 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7632 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7628 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7628 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7614 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7584 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7584 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7582 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7582 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7556 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7556 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7547 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7546 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7543 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7543 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7533 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7532 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7532 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7517 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7517 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7517 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7516 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7515 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD1608 |
Approved |
0.75 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7485 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7471 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7471 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7469 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7468 |
Intermediate Similarity |
NPD943 |
Approved |
0.7458 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7434 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7417 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7416 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.741 |
Intermediate Similarity |
NPD37 |
Approved |
0.7396 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7381 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7381 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7379 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7368 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7325 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7321 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7312 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7302 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7297 |
Intermediate Similarity |
NPD17 |
Approved |
0.7296 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7273 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7258 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7258 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7258 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7258 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7258 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7258 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7258 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7255 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.725 |
Intermediate Similarity |
NPD5958 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD2897 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7246 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7244 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7238 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7238 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7228 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7228 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD411 |
Approved |
0.7226 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7219 |
Intermediate Similarity |
NPD5353 |
Approved |
0.72 |
Intermediate Similarity |
NPD7228 |
Approved |
0.72 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7195
|
Intermediate Similarity |
NPD4661 |
Approved |